In line with the EACS 2024 guidelines [41], ART should be initiated in all individuals with TB/HIV co-infection regardless of CD4 count, with earlier initiation (within 2 weeks) recommended for those with CD4 < 50 cells/μL, except in cases of TB meningitis where ART should be delayed by 4 weeks. This evidence concerns the gene CD4 and coinfection.